GlobalData, July 2010, Pages: 47
migraine market. The report also provides insight on the prevalent competitive landscape and the emerging players expected to bring significant shift in the market positioning of the existing market leaders
Euromonitor International, July 2011, Pages: 24
OTC Triptans in Sweden The growing self-medication trend is a key driver of category sales. OTC triptans are most likely to be purchased by consumers who believe they are suffering from a migraine
Business Insights, Jan 2007, Pages: 224
modulators
Nicotinic receptor agonists
Mu opiate receptor agonists
Delta opiates
MigraineTriptans and NSAIDs
Non-serotonergic treatments
Calcitonin Gene Related Peptide (CGRP)
Gap junction blockers
Business Insights, Oct 2005
in the next few years, however many of the major players are set to perform disappointingly in these traditional markets due to increasing pricing pressure from generic competition and limited differentiation
Jain PharmaBiotech, May 2012, Pages: 798
Pharmacogenetics of epilepsy
Pharmacogenomics of epilepsy
Drug resistance in epilepsy
Future prospects for management of epilepsy
Personalized management of migraine
Individualization of use of triptans
